CTOs on the Move

AIT Laboratories

www.aitlabs.com

 
AIT Laboratories is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.aitlabs.com
  • 2265 Executive Dr
    Indianapolis, IN USA 46241
  • Phone: 317.243.3894

Executives

Name Title Contact Details

Similar Companies

Red Bag Solutions, Inc.

Red Bag Solutions, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Baby and Me Fitness

Baby and Me Fitness is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St. John`s Episcopal Hospital

Episcopal Health Services (EHS) traces its roots almost 150 years back to the Church Charity Foundation which was founded on February 6, 1851 for aged indigent persons and for the welfare of orphans, half orphans, and other destitute children.

Healthplus of Michigan

Healthplus of Michigan is a Flint, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Uroplasty

Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.